YPH.STU Astellas Pharma Inc

Other Metals & Mining Stuttgart Exchange
- EUR
Market cap
-
P/E
14.1x
P/B
2.31x
ROE
29.2%
Dividend yield
141.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is YPH.STU undervalued?

Graham number

The Graham number of Astellas Pharma Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Astellas Pharma Inc fundamental analysis

No fundamental analysis for Astellas Pharma Inc yet.

Astellas Pharma Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Astellas Pharma Inc

There is no Profile data available for YPH.SG.

Full company profile